The virus struck more layer and other commercial poultry farms, as well as backyard flocks in multiple states.
The job losses at the CDC are part of a broader reduction of about 5,200 positions across other government public health ...
Sanofi and Johnson & Johnson’s E. coli vaccine candidate failed to prevent invasive E. coli disease effectively.
Every year, foodborne illnesses sicken 50 million Americans and claim an estimated 3,000 lives. The food safety system is governed by 15 different federal agencies responsible for the enforcement of ...
With no fanfare after 89 reported sick, the FDA has closed its investigation into a romaine lettuce E. coli outbreak without ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over ...
Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...
Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary ...
Due to the discontinuation, Sanofi said that it has recorded an impairment charge before tax of $250 million in the Q4 2024 ...
Sanofi and J&J halted a phase 3 E. coli vaccine trial due to insufficient efficacy. Sanofi's Q4 2024 IFRS EPS dropped by ...
Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing ...